nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Carboplatin—esophageal cancer	0.334	0.415	CbGbCtD
Nitrofurantoin—ABCG2—Cisplatin—esophageal cancer	0.286	0.355	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—esophageal cancer	0.185	0.23	CbGbCtD
Nitrofurantoin—Chronic liver disease—Methotrexate—esophageal cancer	0.0168	0.102	CcSEcCtD
Nitrofurantoin—Fibrosis—Cisplatin—esophageal cancer	0.0077	0.0468	CcSEcCtD
Nitrofurantoin—Superinfection—Capecitabine—esophageal cancer	0.00715	0.0434	CcSEcCtD
Nitrofurantoin—Fibrosis—Capecitabine—esophageal cancer	0.00568	0.0345	CcSEcCtD
Nitrofurantoin—Dyspnoea exertional—Capecitabine—esophageal cancer	0.00537	0.0326	CcSEcCtD
Nitrofurantoin—Anaemia megaloblastic—Methotrexate—esophageal cancer	0.00513	0.0311	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Capecitabine—esophageal cancer	0.00498	0.0302	CcSEcCtD
Nitrofurantoin—Fibrosis—Methotrexate—esophageal cancer	0.00423	0.0257	CcSEcCtD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00413	0.138	CbGpPWpGaD
Nitrofurantoin—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00362	0.022	CcSEcCtD
Nitrofurantoin—Optic neuritis—Cisplatin—esophageal cancer	0.00358	0.0217	CcSEcCtD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00295	0.0981	CbGpPWpGaD
Nitrofurantoin—Lung infiltration—Methotrexate—esophageal cancer	0.00258	0.0156	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Methotrexate—esophageal cancer	0.0025	0.0152	CcSEcCtD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—ABCB1—esophageal cancer	0.00245	0.0817	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00237	0.0791	CbGpPWpGaD
Nitrofurantoin—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00236	0.0143	CcSEcCtD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00223	0.0743	CbGpPWpGaD
Nitrofurantoin—Pleural effusion—Capecitabine—esophageal cancer	0.00212	0.0129	CcSEcCtD
Nitrofurantoin—Body temperature increased—Carboplatin—esophageal cancer	0.00212	0.0129	CcSEcCtD
Nitrofurantoin—ABCG2—Irinotecan Pathway—ABCC2—esophageal cancer	0.00203	0.0676	CbGpPWpGaD
Nitrofurantoin—Tingling sensation—Capecitabine—esophageal cancer	0.00202	0.0123	CcSEcCtD
Nitrofurantoin—Eruption—Methotrexate—esophageal cancer	0.00196	0.0119	CcSEcCtD
Nitrofurantoin—Liver disorder—Methotrexate—esophageal cancer	0.00177	0.0108	CcSEcCtD
Nitrofurantoin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00177	0.0108	CcSEcCtD
Nitrofurantoin—Cyanosis—Methotrexate—esophageal cancer	0.00171	0.0104	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Methotrexate—esophageal cancer	0.00171	0.0104	CcSEcCtD
Nitrofurantoin—Pleural effusion—Methotrexate—esophageal cancer	0.00158	0.00958	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00144	0.00874	CcSEcCtD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—ABCB1—esophageal cancer	0.00141	0.0469	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—XRCC3—esophageal cancer	0.00141	0.0468	CbGpPWpGaD
Nitrofurantoin—Diabetes mellitus—Capecitabine—esophageal cancer	0.00135	0.00823	CcSEcCtD
Nitrofurantoin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0013	0.00792	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00125	0.00758	CcSEcCtD
Nitrofurantoin—Renal impairment—Capecitabine—esophageal cancer	0.00124	0.00752	CcSEcCtD
Nitrofurantoin—Vasculitis—Methotrexate—esophageal cancer	0.00124	0.00752	CcSEcCtD
Nitrofurantoin—Renal failure—Cisplatin—esophageal cancer	0.00121	0.00735	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00121	0.00733	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TYMP—esophageal cancer	0.00118	0.0392	CbGpPWpGaD
Nitrofurantoin—Aplastic anaemia—Methotrexate—esophageal cancer	0.00113	0.00689	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00106	0.00644	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00104	0.00631	CcSEcCtD
Nitrofurantoin—Asthma—Capecitabine—esophageal cancer	0.00102	0.00618	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Methotrexate—esophageal cancer	0.00101	0.00612	CcSEcCtD
Nitrofurantoin—Alopecia—Cisplatin—esophageal cancer	0.000977	0.00593	CcSEcCtD
Nitrofurantoin—Flatulence—Cisplatin—esophageal cancer	0.000948	0.00576	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000929	0.00564	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—MMP14—esophageal cancer	0.000927	0.0309	CbGpPWpGaD
Nitrofurantoin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0009	0.00547	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000893	0.00542	CcSEcCtD
Nitrofurantoin—Renal failure—Capecitabine—esophageal cancer	0.000892	0.00542	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00089	0.0054	CcSEcCtD
Nitrofurantoin—Anaemia—Cisplatin—esophageal cancer	0.000889	0.0054	CcSEcCtD
Nitrofurantoin—Malaise—Cisplatin—esophageal cancer	0.000868	0.00527	CcSEcCtD
Nitrofurantoin—Leukopenia—Cisplatin—esophageal cancer	0.000861	0.00523	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Capecitabine—esophageal cancer	0.000847	0.00515	CcSEcCtD
Nitrofurantoin—Myalgia—Cisplatin—esophageal cancer	0.000819	0.00498	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—CYP2A6—esophageal cancer	0.000817	0.0272	CbGpPWpGaD
Nitrofurantoin—Hepatitis—Capecitabine—esophageal cancer	0.000815	0.00495	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000811	0.00492	CcSEcCtD
Nitrofurantoin—Discomfort—Cisplatin—esophageal cancer	0.000809	0.00492	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000785	0.00477	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Capecitabine—esophageal cancer	0.00077	0.00468	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000769	0.00467	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—esophageal cancer	0.000758	0.0046	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—esophageal cancer	0.00075	0.00456	CcSEcCtD
Nitrofurantoin—Anorexia—Cisplatin—esophageal cancer	0.000749	0.00455	CcSEcCtD
Nitrofurantoin—Chills—Capecitabine—esophageal cancer	0.000731	0.00444	CcSEcCtD
Nitrofurantoin—Alopecia—Capecitabine—esophageal cancer	0.00072	0.00437	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000715	0.00435	CcSEcCtD
Nitrofurantoin—Paraesthesia—Cisplatin—esophageal cancer	0.000705	0.00428	CcSEcCtD
Nitrofurantoin—Dyspnoea—Cisplatin—esophageal cancer	0.0007	0.00425	CcSEcCtD
Nitrofurantoin—Flatulence—Capecitabine—esophageal cancer	0.000699	0.00425	CcSEcCtD
Nitrofurantoin—Decreased appetite—Cisplatin—esophageal cancer	0.000683	0.00415	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000678	0.00412	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—esophageal cancer	0.000676	0.0041	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00067	0.00407	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—SMUG1—esophageal cancer	0.000665	0.0221	CbGpPWpGaD
Nitrofurantoin—Renal failure—Methotrexate—esophageal cancer	0.000664	0.00403	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000658	0.004	CcSEcCtD
Nitrofurantoin—Anaemia—Capecitabine—esophageal cancer	0.000656	0.00398	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Cisplatin—esophageal cancer	0.000647	0.00393	CcSEcCtD
Nitrofurantoin—Malaise—Capecitabine—esophageal cancer	0.00064	0.00389	CcSEcCtD
Nitrofurantoin—Vertigo—Capecitabine—esophageal cancer	0.000637	0.00387	CcSEcCtD
Nitrofurantoin—Leukopenia—Capecitabine—esophageal cancer	0.000635	0.00386	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—esophageal cancer	0.000631	0.00383	CcSEcCtD
Nitrofurantoin—Body temperature increased—Cisplatin—esophageal cancer	0.000621	0.00377	CcSEcCtD
Nitrofurantoin—Cough—Capecitabine—esophageal cancer	0.000619	0.00376	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—esophageal cancer	0.000607	0.00368	CcSEcCtD
Nitrofurantoin—Chest pain—Capecitabine—esophageal cancer	0.000604	0.00367	CcSEcCtD
Nitrofurantoin—Myalgia—Capecitabine—esophageal cancer	0.000604	0.00367	CcSEcCtD
Nitrofurantoin—Discomfort—Capecitabine—esophageal cancer	0.000597	0.00362	CcSEcCtD
Nitrofurantoin—Confusional state—Capecitabine—esophageal cancer	0.000584	0.00355	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Cisplatin—esophageal cancer	0.000579	0.00351	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—esophageal cancer	0.000573	0.00348	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000567	0.00344	CcSEcCtD
Nitrofurantoin—Asthenia—Cisplatin—esophageal cancer	0.000563	0.00342	CcSEcCtD
Nitrofurantoin—Anorexia—Capecitabine—esophageal cancer	0.000552	0.00335	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—esophageal cancer	0.000544	0.00331	CcSEcCtD
Nitrofurantoin—Diarrhoea—Cisplatin—esophageal cancer	0.000537	0.00326	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—esophageal cancer	0.000536	0.00326	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000527	0.0032	CcSEcCtD
Nitrofurantoin—Paraesthesia—Capecitabine—esophageal cancer	0.00052	0.00316	CcSEcCtD
Nitrofurantoin—Dyspnoea—Capecitabine—esophageal cancer	0.000516	0.00313	CcSEcCtD
Nitrofurantoin—Dyspepsia—Capecitabine—esophageal cancer	0.00051	0.0031	CcSEcCtD
Nitrofurantoin—Decreased appetite—Capecitabine—esophageal cancer	0.000503	0.00306	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0005	0.00304	CcSEcCtD
Nitrofurantoin—Vomiting—Cisplatin—esophageal cancer	0.000499	0.00303	CcSEcCtD
Nitrofurantoin—Rash—Cisplatin—esophageal cancer	0.000495	0.00301	CcSEcCtD
Nitrofurantoin—Constipation—Capecitabine—esophageal cancer	0.000495	0.00301	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00049	0.00298	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—esophageal cancer	0.000488	0.00296	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Capecitabine—esophageal cancer	0.000477	0.0029	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—esophageal cancer	0.000476	0.00289	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—esophageal cancer	0.000474	0.00288	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000473	0.00288	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—esophageal cancer	0.000473	0.00287	CcSEcCtD
Nitrofurantoin—Nausea—Cisplatin—esophageal cancer	0.000466	0.00283	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—esophageal cancer	0.000461	0.0028	CcSEcCtD
Nitrofurantoin—Abdominal pain—Capecitabine—esophageal cancer	0.000458	0.00278	CcSEcCtD
Nitrofurantoin—Body temperature increased—Capecitabine—esophageal cancer	0.000458	0.00278	CcSEcCtD
Nitrofurantoin—ABCG2—Iron uptake and transport—HMOX1—esophageal cancer	0.000457	0.0152	CbGpPWpGaD
Nitrofurantoin—Chest pain—Methotrexate—esophageal cancer	0.00045	0.00273	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—esophageal cancer	0.00045	0.00273	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000445	0.0148	CbGpPWpGaD
Nitrofurantoin—Discomfort—Methotrexate—esophageal cancer	0.000444	0.0027	CcSEcCtD
Nitrofurantoin—Confusional state—Methotrexate—esophageal cancer	0.000435	0.00264	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000431	0.00262	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Capecitabine—esophageal cancer	0.000426	0.00259	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000422	0.00256	CcSEcCtD
Nitrofurantoin—Asthenia—Capecitabine—esophageal cancer	0.000415	0.00252	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—KDR—esophageal cancer	0.000414	0.0138	CbGpPWpGaD
Nitrofurantoin—Anorexia—Methotrexate—esophageal cancer	0.000411	0.0025	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000408	0.0136	CbGpPWpGaD
Nitrofurantoin—Diarrhoea—Capecitabine—esophageal cancer	0.000396	0.00241	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—esophageal cancer	0.000395	0.0132	CbGpPWpGaD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000393	0.00238	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—esophageal cancer	0.000387	0.00235	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—esophageal cancer	0.000384	0.00233	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—esophageal cancer	0.000383	0.00233	CcSEcCtD
Nitrofurantoin—Dizziness—Capecitabine—esophageal cancer	0.000383	0.00233	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—esophageal cancer	0.000379	0.0023	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—esophageal cancer	0.000375	0.00228	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000372	0.00226	CcSEcCtD
Nitrofurantoin—Vomiting—Capecitabine—esophageal cancer	0.000368	0.00224	CcSEcCtD
Nitrofurantoin—Rash—Capecitabine—esophageal cancer	0.000365	0.00222	CcSEcCtD
Nitrofurantoin—Headache—Capecitabine—esophageal cancer	0.000363	0.0022	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—esophageal cancer	0.000355	0.00216	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—esophageal cancer	0.000354	0.0118	CbGpPWpGaD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000352	0.00214	CcSEcCtD
Nitrofurantoin—Nausea—Capecitabine—esophageal cancer	0.000344	0.00209	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—esophageal cancer	0.000341	0.00207	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—esophageal cancer	0.000341	0.00207	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000324	0.0108	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Methotrexate—esophageal cancer	0.000317	0.00193	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000311	0.0104	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—esophageal cancer	0.000311	0.0104	CbGpPWpGaD
Nitrofurantoin—Asthenia—Methotrexate—esophageal cancer	0.000309	0.00188	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—esophageal cancer	0.000295	0.00179	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—esophageal cancer	0.000285	0.00173	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—esophageal cancer	0.000274	0.00166	CcSEcCtD
Nitrofurantoin—Rash—Methotrexate—esophageal cancer	0.000272	0.00165	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—esophageal cancer	0.00027	0.00164	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—esophageal cancer	0.000256	0.00155	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000255	0.00848	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—EP300—esophageal cancer	0.000241	0.00802	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000232	0.00772	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000208	0.00693	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000177	0.00588	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000161	0.00537	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.000157	0.00522	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000152	0.00505	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000144	0.00478	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000142	0.00472	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000137	0.00456	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000131	0.00437	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000131	0.00437	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.96e-05	0.00332	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.03e-05	0.00301	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—BLVRB—esophageal cancer	8.88e-05	0.00296	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC52A3—esophageal cancer	8.88e-05	0.00296	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CA1—esophageal cancer	7.55e-05	0.00251	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC10A2—esophageal cancer	7.55e-05	0.00251	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CA2—esophageal cancer	6.9e-05	0.0023	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ADH7—esophageal cancer	6.42e-05	0.00214	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PLCE1—esophageal cancer	6.42e-05	0.00214	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ADH1B—esophageal cancer	5.63e-05	0.00187	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.5e-05	0.00183	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TYMP—esophageal cancer	5.38e-05	0.00179	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.28e-05	0.00176	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP26A1—esophageal cancer	5.23e-05	0.00174	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALOX15—esophageal cancer	5.1e-05	0.0017	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TPI1—esophageal cancer	4.86e-05	0.00162	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTO1—esophageal cancer	4.86e-05	0.00162	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALDOB—esophageal cancer	4.66e-05	0.00155	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GAPDH—esophageal cancer	4.49e-05	0.00149	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CRABP1—esophageal cancer	4.45e-05	0.00148	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GNG7—esophageal cancer	4.23e-05	0.00141	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALDH2—esophageal cancer	3.96e-05	0.00132	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTT1—esophageal cancer	3.77e-05	0.00126	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2A6—esophageal cancer	3.73e-05	0.00124	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTGS1—esophageal cancer	3.53e-05	0.00118	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ENO1—esophageal cancer	3.53e-05	0.00118	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.53e-05	0.00118	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PSME2—esophageal cancer	3.48e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PSME1—esophageal cancer	3.48e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP1B1—esophageal cancer	3e-05	0.001	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.82e-05	0.000941	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HMOX1—esophageal cancer	2.58e-05	0.000859	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ABCB1—esophageal cancer	2.47e-05	0.000824	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CREBBP—esophageal cancer	1.65e-05	0.000551	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NOS3—esophageal cancer	1.48e-05	0.000493	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTGS2—esophageal cancer	1.35e-05	0.000451	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—EP300—esophageal cancer	1.13e-05	0.000375	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CA—esophageal cancer	8.33e-06	0.000277	CbGpPWpGaD
